A tragic lesson in risk management

The drug, branded as Rezzayo, is the first FDA-approved invasive candidiasis treatment in over a decade.

Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.

The drug Leniolisib, now with the brand name Joenja, treats APDA, a genetic disorder that impairs the immune system. Its annual list price will be $547,500.

Learn more about the ins and outs of pharmacy ownership from the experts at First Financial Bank.

Are pharmacists obligated to correct medical misinformation they encounter online?

Regulatory officials said additional requirements are needed in order to approve the drug, which is under review for treatment of myelofibrosis, polycythemia vera, and graft-versus-host disease.